Pramipexole tablets usually refer to pramipexole hydrochloride tablets. Medoxomil usually refers to Dobazepam tablets. Both medications can be taken at the same time. Pramipexole hydrochloride tablets can be used to treat the signs and symptoms of idiopathic Parkinson’s disease, alone or in combination with levodopa. Dobasic hydrazide tablets can be used to treat Parkinson’s disease, symptomatic Parkinson’s syndrome, but not drug-induced Parkinson’s syndrome. Adverse reactions such as consciousness, dizziness, constipation, and dyskinesia may occur during the use of pramipexole hydrochloride tablets. It is contraindicated in persons who are hypersensitive to the active ingredient or any of the excipients of the product. When the drug is taken by Parkinson’s patients with renal impairment, it is necessary to reduce the dosage in conjunction with the instructions or use the drug under medical supervision. Adverse reactions such as hemolytic anemia, transient leukopenia, skin irritation, or thrombocytopenia may occur during the use of Dobasic Acid Tablets. It is not recommended for patients who are allergic to levodopa, benserazide or its excipients. If the disease continues to be unimproved or the symptoms continue to worsen when treated with the drug, it is also necessary to go to the hospital for examination and to adjust the therapeutic measures for the body’s condition.